Breaking News
Subscribe Now 0
👀 Ones to watch: Undervalued stocks to buy before they report Q3 earnings See Undervalued Stocks
Close

Johnson & Johnson (JNJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
165.00 0.00    0.00%
11/10 - Closed. Currency in USD
Type:  Equity
Market:  Peru
ISIN:  US4781601046 
S/N:  JNJ
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 165.00 - 165.00
J&J 165.00 0.00 0.00%

NYSE:JNJ Financials

 
A brief overview of the NYSE:JNJ financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Johnson and Johnson over time.

Johnson & Johnson reported earnings results for the third quarter and nine months ended September 29, 2024. For the third quarter, the company reported sales was USD 22,471 million compared to USD 21,351 million a year ago. Net income was USD 2,694 million compared to USD 26,028 million a year ago. Diluted earnings per share from continuing operations was USD 1.11 compared to USD 1.69 a year ago. For the nine months, sales was USD 66,301 million compared to USD 63,764 million a year ago. Net income was USD 10,635 million compared to USD 31,104 million a year ago. Diluted earnings per share from continuing operations was USD 4.38 compared to USD 3.53 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

JNJ Income Statement

Gross margin TTM 69.43%
Operating margin TTM 27.9%
Net Profit margin TTM 43.91%
Return on Investment TTM 18.08%
 Total Revenue  Net Income
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 01, 2023
Total Revenue 22447 21383 21395 21351
Gross Profit 15580 14879 14680 14971
Operating Income 6694 6310 4730 6421
Net Income 4686 3255 4049 26028

JNJ Balance Sheet

Quick Ratio MRQ 0.77
Current Ratio MRQ 1.07
LT Debt to Equity MRQ 44.22%
Total Debt to Equity MRQ 58%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 01, 2023
Total Assets 181088 171966 167558 166061
Total Liabilities 109550 101946 98784 94833
Total Equity 71538 70020 68774 71228

JNJ Cash Flow Statement

Cash Flow/Share TTM 10.24
Revenue/Share TTM 35.97
Operating Cash Flow  10.44%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 01, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 5633 3657 7863
Cash From Investing Activities -13687 -464 -1202
Cash From Financing Activities 7544 546 -4655
Net Change in Cash -595 3614 2131
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JNJ Comments

Write your thoughts about Johnson & Johnson
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andre Van Laer
Andre Van Laer Oct 11, 2024 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Talc case… poor lawyers, they will not make lots of money anymore on the “victims” anymore?
Volkan Karadağ
Volkan Karadağ Sep 19, 2024 3:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All market is green, what is wrong with this johnson?
Black Rock AL
BlackRockAL Aug 28, 2024 10:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy for the long long term
Lloyd Weimer II
Lloyd Weimer II Jul 25, 2024 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone wondering if the 7 billion settlement on azbestus in the talc suit and the upcoming JAbzine liability cases will have any effect on the jnjbottom line?
Maria Kenny
Maria Kenny Jun 11, 2024 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JNJ bought SWAV accretive to earnings long-term. SWAV was small cap darling in 2023 Lithotripsy breakthroughs. Not sure if analysts will like affect near term on EPS but good add to portfolio.
lance freeman
lance freeman Jun 11, 2024 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice research!
San Marina
San Marina Jun 07, 2024 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is historically bullet proof company with steady stock price growth. Will hit $170 in few months
Dimas Mardjono
Dimasm Apr 29, 2024 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
shite & shite
Zaza Zaza
Zaza Zaza Apr 29, 2024 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go to sleep
jean Bendaci
jean Bendaci Dec 28, 2023 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very good fruit gummies.
Dec 11, 2023 8:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
On its way to $130
Dimas Mardjono
Dimasm Nov 15, 2023 11:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
let's go
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email